Research output per year
Research output per year
Fingerprint
Dive into the research topics where John Bartlett is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis
Karlsson, P., Fyles, A., Chang, L., Arrick, B., L. Baehner, F., Malmstrom, P., Ferno, M., Holmberg, E., Sjöström, M., Liu, F.-F., Cameron, D. A., Williams, L. J., Bartlett, J. M., Dunlop, J., Caldwell, J., Loane, J. F., Mallon, E., Piper, T., Kunkler, I. & Y. Feng, F. & 4 others, , 18 Oct 2024, In: Journal of the National Cancer Institute (JNCI). djae262.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial
Williams, L. J., Kunkler, I., Taylor, K., Dunlop, J., Piper, T., Caldwell, J., Jack, W., Loane, J., Elder, K., Bartlett, J., Dixon, M. & Cameron, D. A., 7 Aug 2024, (E-pub ahead of print) In: The Lancet Oncology. 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole
Chapman, J.-A. W., Bayani, J., SenGupta, S., Bartlett, J. M. S., Piper, T., Quintayo, M. A., Virk, S., Goss, P. E., Ingle, J. N., Ellis, M. J., Sledge, G. W., Budd, G. T., Rabaglio, M., Ansari, R. H., Tozer, R., D'Souza, D. P., Chalchal, H., Spadafora, S., Stearns, V. & Perez, E. A. & 6 others, , 2 Jun 2024, In: Journal of Clinical Oncology. p. JCO2400835Research output: Contribution to journal › Article › peer-review
-
Geographic variation of mutagenic exposures in kidney cancer genomes
Senkin, S., Moody, S., Díaz-Gay, M., Abedi-Ardekani, B., Cattiaux, T., Ferreiro-Iglesias, A., Wang, J., Fitzgerald, S., Kazachkova, M., Vangara, R., Le, A. P., Bergstrom, E. N., Khandekar, A., Otlu, B., Cheema, S., Latimer, C., Thomas, E., Atkins, J. R., Smith-Byrne, K. & Cortez cardoso penha, R. & 59 others, , 1 May 2024, In: Nature. 629, 8013, p. 910-918Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Validation of the prognostic performance of Breast Cancer Index (BCI) in hormone receptor-positive (HR+) postmenopausal breast cancer patients in the TEAM trial
Bartlett, J., Xu, K., Wong, J., Pond, G., Zhang, Y., Spears, M., Salunga, R., Mallon, E., Taylor, K., Hasenburg, A., Markopoulos, C., Dirix, L., J.H van de Velde, C., Rea, D., A. Schnabel, C., Treuner, K. & Bayani, J., 12 Mar 2024, In: Clinical Cancer Research.Research output: Contribution to journal › Article › peer-review
Open AccessFile
-
OPTIMA - Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis
Cameron, D. (Principal Investigator) & Bartlett, J. (Co-investigator)
1/09/22 → 31/12/25
Project: Research
-
PRECISION: Personalised Risk Evaluation in DCIS, International
Bartlett, J. (Principal Investigator)
1/02/21 → 1/01/22
Project: Research
-
Radiotype Dx
Kunkler, I. (Principal Investigator), Bartlett, J. (Co-investigator) & Williams, L. (Co-investigator)
Non-EU industry, commerce and public corporations
20/12/19 → 19/12/22
Project: Research
-